Report cover image

Global Immuno-Oncology Competitive Landscape Professional Research Report 2025

Publisher DIResearch
Published Jan 23, 2025
Length 170 Pages
SKU # DIR19532046

Description

Global Immuno-Oncology Competitive Landscape Professional Research Report 2025



Research Summary

Immuno-oncology is a branch of cancer treatment that focuses on harnessing the body＇s immune system to recognize, target, and eliminate cancer cells. The field explores strategies to enhance the natural ability of the immune system to detect and destroy cancer cells, often by overcoming mechanisms that tumors use to evade immune detection. Immunotherapies in immuno-oncology include checkpoint inhibitors, adoptive cell transfer, cytokines, and cancer vaccines. Checkpoint inhibitors, such as PD-1 and CTLA-4 inhibitors, block proteins that inhibit immune responses, allowing T cells to recognize and attack cancer cells more effectively. Adoptive cell transfer involves manipulating a patient＇s own immune cells outside the body and then reintroducing them to target and destroy cancer cells. Immuno-oncology has shown promising results in treating various types of cancers and is a rapidly evolving field in the quest for more effective and targeted cancer therapies.

According to DIResearch's in-depth investigation and research, the global Immuno-Oncology market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Immuno-Oncology include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Immuno-Oncology. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Immuno-Oncology market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Immuno-Oncology market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Immuno-Oncology industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Immuno-Oncology Include:

Bristol-Myers Squibb

Merck & Co., Inc.

Roche AG

AstraZeneca, Plc

Sanofi S.A.

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc.

Merck KGaA

Immuno-Oncology Product Segment Include:

Immune Checkpoint Inhibitors

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy

Others

Immuno-Oncology Product Application Include:

Hospitals

Drugstores

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Immuno-Oncology Industry PESTEL Analysis

Chapter 3: Global Immuno-Oncology Industry Porter’s Five Forces Analysis

Chapter 4: Global Immuno-Oncology Major Regional Market Size and Forecast Analysis

Chapter 5: Global Immuno-Oncology Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Immuno-Oncology Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Immuno-Oncology Market Overview
1.1 Product Definition and Statistical Scope
1.2 Immuno-Oncology Product by Type
1.2.1 Immune Checkpoint Inhibitors
1.2.2 Cytokine-Based Immunotherapy
1.2.3 Cancer Vaccines
1.2.4 CAR-T Cell Therapy
1.2.5 Others
1.3 Immuno-Oncology Product by Application
1.3.1 Hospitals
1.3.2 Drugstores
1.3.3 Others
1.4 Global Immuno-Oncology Market Size Analysis (2020-2032)
1.5 Immuno-Oncology Market Development Status and Trends
1.5.1 Immuno-Oncology Industry Development Status Analysis
1.5.2 Immuno-Oncology Industry Development Trends Analysis
2 Immuno-Oncology Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Immuno-Oncology Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Immuno-Oncology Market Analysis by Regions
4.1 Immuno-Oncology Overall Market: 2024 VS 2025 VS 2032
4.2 Global Immuno-Oncology Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Immuno-Oncology Revenue and Market Share by Region (2020-2025)
4.2.2 Global Immuno-Oncology Revenue Forecast by Region (2026-2032)
5 Global Immuno-Oncology Market Size by Type and Application
5.1 Global Immuno-Oncology Market Size by Type (2020-2032)
5.2 Global Immuno-Oncology Market Size by Application (2020-2032)
6 North America
6.1 North America Immuno-Oncology Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Immuno-Oncology Market Size by Type
6.4 North America Immuno-Oncology Market Size by Application
6.5 North America Immuno-Oncology Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Immuno-Oncology Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Immuno-Oncology Market Size by Type
7.4 Europe Immuno-Oncology Market Size by Application
7.5 Europe Immuno-Oncology Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Immuno-Oncology Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Immuno-Oncology Market Size by Type
8.4 China Immuno-Oncology Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Immuno-Oncology Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Immuno-Oncology Market Size by Type
9.4 APAC (excl. China) Immuno-Oncology Market Size by Application
9.5 APAC (excl. China) Immuno-Oncology Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Immuno-Oncology Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Immuno-Oncology Market Size by Type
10.4 Latin America Immuno-Oncology Market Size by Application
10.5 Latin America Immuno-Oncology Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Immuno-Oncology Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Immuno-Oncology Market Size by Type
11.4 Middle East & Africa Immuno-Oncology Market Size by Application
11.5 Middle East & Africa Immuno-Oncology Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Immuno-Oncology Market Revenue by Key Manufacturers (2021-2025)
12.2 Immuno-Oncology Competitive Landscape Analysis and Market Dynamic
12.2.1 Immuno-Oncology Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Bristol-Myers Squibb Immuno-Oncology Product Portfolio
13.1.3 Bristol-Myers Squibb Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Merck & Co., Inc.
13.2.1 Merck & Co., Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Merck & Co., Inc. Immuno-Oncology Product Portfolio
13.2.3 Merck & Co., Inc. Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Roche AG
13.3.1 Roche AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Roche AG Immuno-Oncology Product Portfolio
13.3.3 Roche AG Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 AstraZeneca, Plc
13.4.1 AstraZeneca, Plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 AstraZeneca, Plc Immuno-Oncology Product Portfolio
13.4.3 AstraZeneca, Plc Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Sanofi S.A.
13.5.1 Sanofi S.A. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Sanofi S.A. Immuno-Oncology Product Portfolio
13.5.3 Sanofi S.A. Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Dendreon Pharmaceuticals
13.6.1 Dendreon Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Portfolio
13.6.3 Dendreon Pharmaceuticals Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Novartis
13.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Novartis Immuno-Oncology Product Portfolio
13.7.3 Novartis Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 Gilead Sciences Inc.
13.8.1 Gilead Sciences Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Gilead Sciences Inc. Immuno-Oncology Product Portfolio
13.8.3 Gilead Sciences Inc. Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Merck KGaA
13.9.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Merck KGaA Immuno-Oncology Product Portfolio
13.9.3 Merck KGaA Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Immuno-Oncology Industry Chain Analysis
14.2 Immuno-Oncology Industry Raw Material and Suppliers Analysis
14.2.1 Immuno-Oncology Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Immuno-Oncology Typical Downstream Customers
14.4 Immuno-Oncology Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us